Latest Content

A friend’s 28-year cancer journey taught one woman how to find hope, stay optimistic and live fully after her own incurable cancer diagnosis.

FDA approves Rasonque, a first-in-class targeted therapy for metastatic pancreatic cancer, offering a new treatment option for eligible patients.

A testicular cancer survivor shares his story of early detection, embracing failure, and redefining success through hard-won life lessons.

Dolly Parton has died at 80 following a brief battle with cancer. Learn what is known about her diagnosis, legacy and resources for those affected.

In a new video Q&A with CURE, Dr. Silverman answers the most searched childhood leukemia questions.

An incoming medical oncologist at the University of Cincinnati on how patient values shape treatment, and what precision medicine can now target.

Breast oncologist Dr. Zunairah Shah explains how breast cancer research is improving treatment, biomarker testing and options such as antibody-drug conjugates.

FDA approves Ziihera combinations for first-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma, expanding treatment options.

Dr. Matthew Carr explains how CAR T-cell therapy works, who may be eligible and how doctors decide when to treat or monitor cancer.

After years of writing about my own cancer, I sat down to write my 94-year-old mother's obituary and learned how differently the two forms hit.

Nicole Echols discusses Lung Cancer Initiative, reducing lung cancer stigma, biomarker testing, early detection and support for patients and caregivers.

Dr. Jia Luo explains how chemotherapy, targeted therapy and immunotherapy work for lung cancer, plus tips for managing treatment side effects.

Jill May, RN, BSN, OCN, of Allina Health Cancer Institute, guided a liver cancer patient and his caregiver wife through three years of treatment, setbacks and ultimately hospice care with unwavering devotion.